Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 530921000036115 | beractant 200 mg / 8 mL intratracheal suspension, 8 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 530931000036118 | beractant 200 mg/8 mL intratracheal suspension, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| beractant 200 mg/8 mL intratracheal suspension, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| beractant 200 mg/8 mL intratracheal suspension, vial | Is a | beractant | true | Inferred relationship | Some | ||
| beractant 200 mg/8 mL intratracheal suspension, vial | has intended active ingredient | beractant | true | Inferred relationship | Some | 1602342836 | |
| beractant 200 mg/8 mL intratracheal suspension, vial | has Australian BoSS | beractant | true | Inferred relationship | Some | 1602342836 | |
| beractant 200 mg/8 mL intratracheal suspension, vial | has manufactured dose form | intratracheal suspension | true | Inferred relationship | Some | ||
| beractant 200 mg/8 mL intratracheal suspension, vial | has unit of use | vial | true | Inferred relationship | Some | 1602342837 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial | Is a | True | beractant 200 mg/8 mL intratracheal suspension, vial | Inferred relationship | Some | |
| beractant 200 mg/8 mL intratracheal suspension, 8 mL vial | has MPUU | True | beractant 200 mg/8 mL intratracheal suspension, vial | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR